STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma

MLA

Ana Paula Morelli, et al. “STAT3 Contributes to Cisplatin Resistance, Modulating EMT Markers, and the MTOR Signaling in Lung Adenocarcinoma.” Neoplasia: An International Journal for Oncology Research, vol. 23, no. 10, Oct. 2021, pp. 1048–58. EBSCOhost, https://doi.org/10.1016/j.neo.2021.08.003.

APA

Ana Paula Morelli, Tharcísio Citrângulo Tortelli, J., Mariana Camargo Silva Mancini, Isadora Carolina Betim Pavan, Luiz Guilherme Salvino Silva, Matheus Brandemarte Severino, Daniela Campos Granato, Nathalie Fortes Pestana, Luis Gustavo Saboia Ponte, Guilherme Francisco Peruca, Bianca Alves Pauletti, Daniel Francisco Guimarães dos Santos, J., Leandro Pereira de Moura, Rosângela Maria Neves Bezerra, Adriana Franco Paes Leme, Roger Chammas, & Fernando Moreira Simabuco. (2021). STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma. Neoplasia: An International Journal for Oncology Research, 23(10), 1048–1058. https://doi.org/10.1016/j.neo.2021.08.003

Chicago

Ana Paula Morelli, Jr Tharcísio Citrângulo Tortelli, Mariana Camargo Silva Mancini, Isadora Carolina Betim Pavan, Luiz Guilherme Salvino Silva, Matheus Brandemarte Severino, Daniela Campos Granato, et al. 2021. “STAT3 Contributes to Cisplatin Resistance, Modulating EMT Markers, and the MTOR Signaling in Lung Adenocarcinoma.” Neoplasia: An International Journal for Oncology Research 23 (10): 1048–58. doi:10.1016/j.neo.2021.08.003.